Currently submitted to: JMIR Formative Research
Date Submitted: May 3, 2026
Open Peer Review Period: May 3, 2026 - Jun 28, 2026
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Patient-Centered Development and Dissemination of MTCEducate.org, an Online Educational Resource and Patient Decision Aid for Medullary Thyroid Cancer
ABSTRACT
Background:
Patients with rare cancers experience clinical vulnerability owing to limited expert clinicians, equivocal treatment options, and a lack of accessible, reliable information. Medullary thyroid cancer (MTC) is a rare cancer characterized by an advanced, progressive, chronic disease state that often has clinical equipoise in treatment decisions.
Objective:
In a previous needs assessment study, an MTC stakeholder group of patients, caregivers, and clinicians identified needs for patient and caregiver education regarding each disease stage and for effective strategies for patient-clinician communication. Here, we report the patient-centered development of a novel online educational resource and patient decision aid, MTCEducate.org, as well as its online dissemination and usability and acceptability analysis.
Methods:
Working with the same stakeholder group as in the needs assessment and additional patient input, we used the identified needs to guide the development and refinement of MTCEducate.org, e.g., by using storyboarding with iterative feedback. The finalized site was strategically promoted through patient support organizations, social media platforms, national conferences, the American Thyroid Association, and a robust MTC Registry listserv. Site metrics were assessed via Google Analytics for one year following site publication, and site usability and acceptability were evaluated via a confidential survey embedded within the website.
Results:
MTCEducate.org underwent six rounds of stakeholder feedback before its online dissemination in April 2023. Over the first year after publication, the site had 2079 unique visitors and 376 return users. To access the site, 63.6% of visitors used a mobile device, and 36.5% used a desktop computer or tablet. The site had visitors from 69 countries; most visitors (69.3%) were from the United States. Visitors accessed the site most often via direct links found in emails, newsletters, or X posts (51.6%), followed by Facebook (44.8%). Seventy-six visitors fully completed the site usability and acceptability survey. Most respondents identified as women (73%), non-Hispanic (92%) and White (96%). Most respondents were ≥45 years (87%), had an associate’s degree or higher (92%), and were MTC patients or survivors (92%). Most respondents correctly answered MTC knowledge–based questions about tumor markers (96%), lymph node dissection (93%), and Food and Drug Administration–approved medications (73%). Most respondents found the site easy to use (88%) and well-integrated (84%) and indicated that they could learn to use it quickly (86%) and confidently (81%).
Conclusions:
Using a patient-centered approach, we created MTCEducate.org, an online patient decision aid, whose multipronged deployment reached an international audience. MTCEducate.org’s format and content were well received and had high usability and acceptability. The site visitors’ lack of racial and ethnic diversity and their advanced educational status underscore the need to understand the preferred access and communication styles and educational resources desired by underrepresented populations.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.